ArticleOxford medical case reports2025

Durable clinical and metabolic response to Trastuzumab Deruxtecan in heavily Pretreated male HER2-low metastatic breast cancer: a case report.

Oumaima Lamsyah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.